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ABSTRACT 
Cholesterol (Chol) is an important lipid in cellular membranes functioning both 
as a membrane fluidity regulator, permeability regulator and co-factor for some 
membrane proteins, e.g. G-protein coupled receptors. It also participates in the 
formation of signaling platforms and gives the membrane more mechanical 
strenght to prevent osmotic lysis of the cell. The sterol structure is very 
conserved and already minor structural modifications can completely abolish its 
membrane functions. The right interaction with adjacent lipids and the 
preference of certain lipid structures over others are also key factors in 
determining the membrane properties of cholesterol. Because of the many 
important properties of cholesterol it is of value to understand the forces and 
structural properties that govern the membrane behavior of this sterol.  
In this thesis we have used established fluorescence spectroscopy methods to 
study the membrane behavior of both cholesterol and some of its 3β-modified 
analogs. Using several fluorescent probes we have established how the acyl 
chain order of the two main lipid species, sphingomyelin (SM) and 
phosphatidylcholine (PC) affect sterol partitioning as well as characterized the 
membrane properties of 3β-aminocholesterol and cholesteryl phosphocholine. 
We concluded that cholesterol prefers SM over PC at equal acyl chain order, 
indicating that other structural properties besides the acyl chain order are 
important for sphingomyelin-sterol interactions. A positive charge at the 3β 
position only caused minor changes in the sterol membrane behavior compared 
to cholesterol. A large phosphocholine head group caused a disruption in 
membrane packing together with other membrane lipids with large head groups, 
but was also able to form stable fluid bilayers together with ceramide and 
cholesterol. The Ability of the large head group sterol to form bilayers together 
with ceramide was further explored in the last paper where cholesteryl 
phosphocholine/ceramide (Chol-PC/Cer) complexes were successfully used to 
transfer ceramide into cultured cells. 
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1. INTRODUCTION 
For life to be able to form there was a need for compartmentalization, the 
molecules of life had to concentrate and form defined spaces. The cells that 
formed had to be able to distinguish the outside from the inside, one space from 
the other and to create environments with different properties enabling energy to 
be harvested and stored. The barrier could not be impermeable, since life is 
constantly evolving, changing and adapting, sensing its environment and 
sending out signals as well as acquiring energy. This semi-permeable 
compartmentalization was achieved with the formation of lipid bilayers, cellular 
membranes, composed of amphiphilic lipids clustering together to form a 
bilayer. As evolution progressed, the membranes developed into 
macromolecular structures comprising the lipid bilayer and various membrane 
proteins, attached to or embedded in the bilayer. The cytoskeleton connected the 
inner monolayer to interior parts of the cell and the glycocalyx outer leaflet 
served as a cell-cell recognition site (1). Although at first thought to be a rather 
static structure, it is now known that the lipid bilayer has to be highly dynamic, 
constantly changing structure and composition in order to support cell viability. 
Interactions between lipids will determine the biophysical properties of the 
membrane, and the cell regulates many of its membrane functions by regulating 
the lipid composition. The properties of the membrane can affect the function 
and the conformational state of membrane proteins and vise versa. The 
physiological state of the cell is thereby partly determined by the physical state 
of the lipid bilayer (2;3). The membrane lipids can also function as “lipid second 
messengers” or as a source for the release of signaling molecules (4;5). In 
mammalian cells one of the key players in membrane regulation is cholesterol. It 
has the ability to improve packing of loosely packed membranes as well as make 
highly dense regions more fluid to accommodate lateral transport. It can also 
regulate ion permeability and help to maintain the electrochemical gradient 
across the plasma membrane (6). By regulating the cholesterol content in its 
membranes the cell can regulate the fluidity, thickness and permeability of these 
membranes. The understanding of how cholesterol is able to perform these tasks 
is largely contributed to the molecular structure of cholesterol and the lipids with 
which it interacts. One way of studying these interactions is to alter the chemical 
structure of cholesterol and then investigate how the alterations affect the 
molecular behavior. The results can then be used to evaluate which properties 
are crucial and by which molecular mechanisms cholesterol interacts with other 
lipids in present in the membrane.  
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2. REVIEW OF THE LITERATURE 
2.1. Biological membranes 
Most cell membranes are built up of a double layer of amphipihilic molecules, 
called lipids (Fig. 1). Because these molecules have both a hydrophobic and a 
hydrophilic part they will tend to self aggregate into structures where the 
hydrophobic parts are shielded from water. The amphiphilic nature of the lipids 
will cause them to aggregate into a double layer structure, a bilayer where the 
hydrophobic acyl chains face each other and the hydrophilic polar head groups 
face the aqueous phase on both sides of the bilayer. By adopting this structure, 
the unfavorable disruption of the hydrogen bond network between water 
molecules by the hydrophobic parts of the lipids is minimized. Thus these 
structures will form spontaneously at physiological temperatures. The lipids 
form the bulk membrane and the functional groups of the participating lipids 
will determine the membrane properties of both the micro- and 
macroenvironment of that membrane.  
 
 
Figure 1. Schematic picture of the cell membrane structure, lipids in red/yellow and 
proteins in blue (en.wikipedia.org, reprinted by permission of the author Mariana Ruiz). 
 
A biological membrane also contains a large number of proteins (Fig. 1). The 
proteins can span the bilayer completely (integral proteins) or can be embedded 
or attached to only one of the leaflets (peripheral proteins). They can also form 
channels or pores in the membrane through which a controlled efflux and influx 
of small molecules and nutrients can take place. The proteins as well as the lipids 
can be decorated with carbohydrates to form glycoproteins and glycolipids, 
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important e.g. in cell to cell recognition. In the cytosolic leaflet some proteins are 
anchored to cytoskeletal filaments, e.g. actins giving the cell its shape and 
structural strength. The plasma membrane, the largest organelle of the cell is 
present both in eukaryotes and prokaryotes and has a thickness of ~4 nm (1).  
 
2.2. Lipid structure 
Apart from being amphiphilic, the properties of membrane lipids can vary 
significantly. A cell membrane is composed of hundreds to thousands of 
different lipid species and different subcellular compartment display variations 
in their lipid composition (7). Lipids can be classified based on their structural 
features. The major lipid classes present in mammalian cell membranes are 
glycerophospholipids, sphingolipids and sterols (cholesterol in mammalian 
cells). Sterols share little resemblance with the other lipids but like the other 
lipids it is an amphiphilic molecule with a hydrocarbon backbone.   
2.2.1. Glycerophospholipids 
Glycerophospholipids, the most abundant lipid species in mammalian cells, are 
members of the larger glycerolipid family and shares the common backbone of L-
glycerophosphate. The three hydroxyl groups of glycerol, named sn-1, sn-2 and 
sn-3, are coupled to a polar phosphate group (sn-3 position) and two acyl chains 
of varying length and degree of saturation (sn-1 and sn-2 position) (8). The 
phosphate can bind additional chemical groups ranging from the small hydroxyl 
group to very large and complex oligosaccharides, forming an array of different 
lipids with markedly different membrane properties. The most common group is 
a choline group, forming phosphatidylcholine or PC for short. PCs with different 
acyl chain lengths and saturation make up the bulk membrane in eukaryotic 
cells, the most common being 1-palmitoyl-2-oleoyl-sn-glycero-
phosphatidylcholine (POPC, Fig 2A.). This molecule has also been used in the 
model membrane work in this thesis to represent the bulk membrane. Other 
common phospholipids in mammalian membranes include phosphatidylserine 
(PS), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and 
phosphatidylglycerol (PG). 
2.2.2. Sphingolipids 
Sphingolipids are the second most abundant phospholipid species in 
mammalian cells, composing 20-25% of the total phospholipid content in the 
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outer leaflet of the plasma membrane (9). Apart from their structural role they 
also have a functional role as precursors for intracellular messengers and are also 
able to, together with cholesterol, function as modulators of membrane fluidity. 
Sphingolipids were first described in the late 19th century by Thudicum (10), who 
also gave them their name, derived from the mythical Sphinx in Luxor, Egypt. 
Later in 1947 Carter determined the first structure of a sphingolipid and also 
suggested that all lipids derived from sphingosine should be classified as 
sphingolipids (11). Sphingolipids differ from glycerophospholipids in that they 
have a sphingoid long-chain base with functional groups and amide linked acyl 
chains attached as the structural backbone. The structure of the sphingoid 
backbone can vary and there are more than sixty different variations known 
amongst the cells of animals, plants and microorganisms. The most basic 
sphingoid backbone structure is sphinganine whereas the most abundant in 
human cells is the unsaturated derivative of sphinganine, sphingosine ((2S, 3R)-
2-amino-4-octadecene-1,3-diol), an unsaturated 18 carbon long amino alcohol 
with a trans double bond between C4 and C5 (12). There are exceptions, in 
human lens tissue for example it is sphinganine, not sphingosine, which account 
for more than 50% of the sphingolipid backbone structure (13). 
The structural variation among sphingolipids is caused by a difference in the 
sphingoid base, the hydrophilic head group attached to the C1 position and the 
difference in length and unsaturation level of the hydrophobic acyl chain 
attached to the amine. The most common head groups are phosphate, 
phosphorylcholine and different carbohydrates, and the most common acyl 
chains are 16:0, 18:0, 24:1 and 24:0. The acyl chain length of sphingosine 
corresponds to an about 13.5 carbon chain long sn-1 chain in a 
glycerophospholipids (14), leading to acyl chain mismatch in most sphingolipid 
species (14). Sphingolipids can also be hydroxylated at various positions in the 
hydrocarbon chain, for example about half of the glycosphingolipids found in 
human brain tissue have a hydroxyl group at the alpha position in the N-acyl 
chain (15).  
Sphingomyelin (SM) is the most abundant sphingolipid in mammalian cells. The 
backbone of SM consists of sphingosine, and a phosphatidylcholine head group 
attached to the C1 carbon. Although the head groups of PC and SM are identical, 
the interface regions are different. Due to the amide- and the 3-hydroxy groups, 
SM is able to act both as a hydrogen bond donor and acceptor, whereas PC only 
can act as an acceptor (16). This may also lead to a different orientation and 
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mobility of the SM head group compared to that of PC (17). SM also has a trans 
double bond between C4 and C5, making the sphingosine backbone more rigid 
(18;19). The amide linked fatty acid of SMs are usually long, between 16 and 26 
carbons and are more saturated than those present in PC lipids (12;20;21). If 
double bonds are present, they are often found further away from the interface 
region than in PC causing less disturbance in the acyl chain packing (22). The 
most common acyl chains are 16:0 (Fig. 2B) and 18:0, mostly found in peripheral 
cell membranes whereas longer 24:0 and 24:1 acyl chains are abundant in the 
myelin sheets of neural axons (22-24).  
 
A 
 B 
            C  
Figure 2. Molecular structures of: 1-palmitoyl-2-oleoyl-phosphatidylcholine (A), 
palmitoyl-sphingomyelin (B) and palmitoyl-ceramide (C) 
 
Ceramide (Cer) is a hydrophobic lipid and a biosynthetic precursor for SM. It 
lacks the head group at C1 and therefore has a considerately smaller molecular 
area than SM or PC. Ceramide can be generated via de novo synthesis, 
degradation of SM by sphingomyelinases or via the salvage pathway which re-
uses long-chained sphingoid bases from the lysosomal degradation pathway of 
sphingolipids. In addition to the sphingosine long-chain base (also present in 
SM) ceramides can be formed from over 50 different long chain bases with 
varying structure. For example the double bond between C4 and C5 in the 
sphingoid base can be saturated to form dihydroceramide. Hydroxylations at 
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various positions of the long-chain base are also common. The N-linked acyl 
chain is usually between 14 and 26 carbons long (Fig. 2C) but ceramides with an 
acyl chain longer than 36 carbons has been reported (25). The structure of the N-
linked acyl chain has been shown to be important for the function and location of 
ceramide. Ceramide is a very versatile molecule and important both as a 
structural component and a bioactive molecule as well as a precursor for more 
complex sphingolipids. It has been proposed that ceramide is able to form pores 
in the plasma- and mitochondrial membranes as well as ceramide rich platforms, 
which are thought to be important in signal transduction. Ceramide is also, 
under certain conditions, able to displace cholesterol from SM/Chol ordered 
domains (26). 
 
2.3. Sterols 
Sterols are a unique class of membrane components, which are almost 
completely hydrophobic and has a unique structure compared to other 
membrane lipids. The common structural feature for all sterols is the ring 
structure. Different organisms have adopted different carbon ring arrangements 
with differences also to the decoration of these rings. Cholesterol (mammalian 
cells), ergosterol (yeast) and stigmasterol and sitosterol (plant cells) are the most 
abundant sterols in biological membranes. Apart from being important 
constituents of membranes, sterols also have a regulatory role, for example many 
human sex hormones are synthesized with cholesterol as the precursor.  
2.3.1. Cholesterol 
Cholesterol was first isolated from gallstones in 1789. Cholesterol is synthesized 
from acetyl CoA in the endoplasmic reticulum (ER) and to some extent in 
peroxisomes. All human cells with the exception of the red blood cells are 
capable of producing cholesterol. Cholesterol consist of a sterol part with four 
hydrocarbon rings, a hydrocarbon chain attached to C17, a double bond between 
C5 and C6, two methyl groups at C10 and C13 and a polar hydroxyl group at C3 
(Fig. 3). The effective length of a cholesterol molecule in the membrane has been 
estimated to correspond to a 17 carbon long, all-trans acyl chain (27). Most of the 
cellular cholesterol (40-90%) is found in the plasma membrane whereas 
mitochondria and ER have the lowest cholesterol content of all cellular 
membranes (28;29). 
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Cholesterol is a key player in maintaining the electrochemical gradient over the 
plasma membrane in animal cells. Animal cells mainly use sodium to maintain 
the gradient and the fused ring structure of cholesterol is thought to prevent 
sodium ion leakage through the plasma membrane (6). Cholesterol has also been 
shown to directly affect the function of some membrane proteins involved in 
membrane trafficking and cell signaling including the G-protein coupled 
receptors (30). Cholesterol is also used as a building block, functioning as a 
precursor for steroid hormones, vitamin D and bile acids (31;32). Many diseases 
have been directly linked to cholesterol homeostasis, the best recognized ones 
being cardiac and brain vascular diseases and dementia (33;34).  
 
Figure 3. Molecular structure of cholesterol. 
 
 
2.4 Membrane structure 
The first proposed models for biological membrane structures came from 
Langmuir monolayer studies performed in the early 20th century. In 1925, Gortel 
and Grendel proposed the bilayer structure composed of two layers of 
amphiphilic molecules arranged with the polar head group facing water on both 
sides of the bilayer (35). Since this first description the membrane model has been 
refined several times (36). In 1972, Singer and Nicolson proposed the fluid 
mosaic model introducing the concept of peripheral and integral membrane 
proteins capable of diffusing laterally within the membrane (37). During the 
following decades this model has been revised and updated a number of times, 
both regarding lipid distribution and protein concentration (36). The abundance 
of transmembrane proteins and their importance has also been of growing 
interest. Some research estimate that protein content in membranes can reach as 
high as 50%. Transmembrane and lateral distribution of lipids has been shown to 
be heterogeneous. Simons and Ikonen introduced the term “lipid rafts” in 1997, 
proposing that lipids do not diffuse freely as proposed in the fluid mosaic model. 
HO
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Instead there is a clear difference in segregation of different lipids between 
different areas in the membrane (38;39). Regions with high sphingolipid and 
cholesterol contents described as microdomains or “lipid rafts”. These domains 
have since been suggested to have a higher degree of order than the surrounding 
areas and also that they could cause specific proteins to cluster within these 
domains. Because of the difference in lipid affinity between different lipid 
species and the formation of the lipid rafts, lateral movements in the bilayer will 
be restricted, at least to a certain degree. Single lipid tracking has shown that the 
rate of collision between a labeled lipid and oxygen is fast in the lipid bulk 
membrane and is slowed down in protein-rich membrane domains containing 
cholesterol (40). These findings are consistent with the lipid raft hypothesis, but 
can also be explained by the high protein content in cells and the underlying cell 
matrix structures such as actin networks and intermediate filaments (41). 
2.4.1. The entropy effect and lipid aggregations 
The driving force behind the formation of lipid membranes is the hydrophobic 
effect, based on the second law of thermodynamics (the entropy of an isolated 
system never decreases) (22;36;42). When lipids are mixed with water they will 
disrupt the hydrogen bonding network between the water molecules leading to a 
decrease in entropy which is not thermodynamically favorable. The decrease in 
entropy can be minimized if the lipids and water separate into two phases, 
minimizing the contact between water and the hydrophobic parts of the lipids 
(36;42). Depending on the structure of the lipids, the temperature and the 
composition, different forms of lipid aggregates are adopted (36). In biological 
context four different arrangements are relevant; the micelles, hexagonal and 
inverted hexagonal phase and bilayers. The parameters that defines the 
aggregation behavior are the critical length of the acyl chain (l), the head group 
area (a) and the acyl chain volume (V) (22;43). These can be combined in the 
critical packing parameter, S = V/al, defining which type of lipid aggregate that is 
formed (Fig. 4). Ion concentration, pH, temperature etc. of the solution will affect 
the packing parameter by affecting V, a and l. If S ≤ 0.33 spherical micelles will be 
formed, an S value between 0.33 and 0.5 will form non-spherical micelles, if 0.5 < 
S ≤ 1 planar bilayers are formed and if S > 1, an inverted hexagonal structure is 
be formed. One important property of S is that it is additive, i.e. a lipid with an S 
value < 0.33 and one with a value > 1 can form bilayers when mixed together (44). 
The most relevant biological aggregate is the bilayers which are also the lipid 
aggregate studied in this thesis. Lamellar bilayers will be discussed in more 
detail in section 2.4.2. 
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Figure 4. The lipid aggregate formed dependents on the molecular geometry of the lipid 
and can be described by S = V/al (see text). 
 
 
Both the lateral and transmembrane distribution will also be affected by the 
overall structural shape of the lipid. Lipids with a large head group compared to 
their acyl chain volume e.g. lysophospholipids (S ≤ 0.33) will induce what is 
called positive membrane curvature (45), i.e. the acyl chains will curve inwards 
towards one another to facilitate the large head groups without disrupting the 
hydrophobic packing. These cone-shaped lipids primarily form micellar 
structures (46). Lipids were the head group size and acyl chain size match will 
not induce any membrane curvature and thus form planar bilayers (0.5 < S ≤ 1). 
Lipids with small head groups compared to the acyl chain size will induce a 
negative membrane curvature (S > 1) where the head groups will curve inwards 
to facilitate the large acyl chains. These inverted cone-shaped lipids form 
hexagonal phases, one example being the hexagonal phase induced by high 
ceramide concentration (45;47). The structure of ceramide promotes the 
formation of hexagonal phases and membrane vesiculation (48). Vesicle leakage 
and thermotropic lamellar-to-inverted non-lamellar phase transition was first 
shown by Ruiz-Argüello et al. (49) and later studies in situ (50;51) have 
confirmed the vesicle leakage of SMase treated SM-containing mixed 
membranes. In most cellular membranes lipids that induce both positive and 
negative curvature as well as bilayer forming lipids will be present. Since most 
membranes can be considered flat the lipids inducing positive and negative 
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curvature gives rise to membrane tension (52) which could activate or inactive 
some transmembrane proteins (53). 
2.4.2. Bilayer phases 
The lateral segregation of lipids leads to the formation of distinct domains with 
different compositions. The segregations is however never absolute nor is it static 
but the domain components are constantly interchanging with those of the 
surrounding membrane. These domains form different types of lamellar phases, 
i.e. the gel phase (Lβ), liquid disordered (Ld), liquid ordered (Lo) and ripple phase 
(Pβ’). The phase that will be adopted depends both on the structure and chemical 
properties of the lipid as well as on external factors such as temperature, 
hydration, ionic strength, pressure and pH. A temperature dependent phase 
behavior is the most studied one and techniques such as differential scanning 
calorimetry (DSC), x-ray diffraction and 31P-nuclear magnetic resonance (NMR) 
spectroscopy have been used in such studies. 
At subzero temperatures most SM and PC bilayers are in a lamellar gel phase, Lβ 
(Fig. 5A). In the Lβ phase the head groups of the lipids are hexagonally arranged 
at the membrane surface and the acyl chains have restricted rotational mobility 
and are in an extended, all-trans configuration. The acyl chains are also tilted in 
respect to the bilayer normal (1;36;54). When the bilayer is heated, it will undergo 
a phase transition from the gel phase to a liquid crystalline phase, also called a 
disordered phase, Ld (Fig. 5B). The temperature at which this transition occurs is 
called Tm and dependens on the lipid structure. Above the Tm the lipid bilayer 
will be in the Ld phase where the molecular motion is substantially increased and 
where gauche conformations in the acyl chains dominate (1;36;54). The molecular 
cross-section area is also substantially increased, thus leading to the lateral 
expansion of the bilayer as well as an increase in hydration. (54). 
Because of the more saturated acyl chains allowing for stronger van der Waals 
interactions SMs have higher Tm compared to PCs. Possible double bonds in the 
SM acyl chain are also often further away from the membrane-water interphase, 
causing a smaller disordering effect than those in the acyl chains of PC which are 
closer to the interphase. SMs could also form a more extensive hydrogen 
bonding network compared to PC, thus increasing the amount of energy needed 
to give the system its fluid nature. The effect of the seemingly small structural 
differences becomes clear when looking at the Tm. The most abundant SMs (C16-
24) have a Tm of 40-50 °C whereas the most abundant PCs (C16-20) have a Tm of ≤ 
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0 °C (55;56). Another crucial parameter determining the Tm is the acyl chain 
length. Both for SM and PC there is a curvy-linear relationship between Tm and 
the number of acyl carbons (55;57). 
When cholesterol is added to a bilayer it can induce a third phase, the liquid 
ordered phase (Lo) phase (Fig. 6). The rigid ring structure of cholesterol will 
promote stronger van der Waals interactions between the acyl chains, thus 
increasing their effective length and decreasing the acyl chain volume. This will 
lead to an increase of the membrane thickness. Addition of cholesterol will cause 
the acyl chains to pack more densely, similar to that in the Lβ phase. The 
rotational freedom, however, will be less hindered resembling that of the Ld 
phase (58-60). The Lo phase can therefore be considered an intermediate between 
the Ld and Lβ phases, something which is also evident from the molecular 
diffusion rates, i.e. Lo displays intermediate diffusion rate as compared to the Lβ 
and Lo phases (61;62).  
 
                      A                B 
                               
 
Figure 5. Schematic picture of a gel phase (A) and a liquid disordered phase (B) 
 
2.4.3. Liquid ordered phase 
Addition of cholesterol to a bilayer will promote lateral phase separation 
resulting in a coexistence of the Lo and Ld or Lo and Lβ phases. The exact nature 
and formation of such a phase separation dependens both on the lipid structure 
as well as the physiological environment such as temperature and membrane 
curvature. In model membranes cholesterol preferably forms Lo phases together 
with saturated phospholipids (63-65)(Fig. 6). Since SM is usually the most 
common saturated lipid in biological systems it is highly likely that SM-
cholesterol ordered domains are the most common ordered structure in cellular 
membranes. The strength of interaction between cholesterol and SMs in the Lo 
phase is dependent on the lipid structure, head group properties, hydrogen 
bonds, acyl chain length and degree of unsaturation (66-73). By measuring the 
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cholesterol desorption rate from monolayers by the compound cyclodextrin (CD) 
one can obtain an approximate value for the interaction strength of cholesterol 
and different lipids. From such studies it has been observed that the desorption 
decreases linearly with increasing acyl chain length of saturated PCs, while the 
chain length of SMs does not have a major effect on cholesterol desorption from 
monolayers (66). The affinity of sterol for membrane lipids can also be assessed 
by comparing the distribution of cholesterol between unilamellar vesicles and 
CD (74;75) (for details see Methods, section 4.3.5.).  
 
 
 Figure 6. Schematic picture of a liquid ordered phase where cholesterol is shown in red. 
 
2.4.4. Model membranes  
Lipid vesicles were first described by Bangham and co-workers in the 1960s 
(76;77) and has since then been widely used as models for cellular membranes. 
Lipid vesicles have been prepared with both distinct lateral and transmembrane 
distribution. It is also possible to insert transmembrane peptides to the bilayer 
and even purified protein complexes have been successfully incorporated into 
vesicles. Cargo molecules can be loaded into the vesicles in the preparation stage 
to monitor membrane leakage for example. Common methods of vesicle 
preparation will yield large multilamellar vesicles of different sizes than can then 
be further processed by sonication and membrane extrusion to control both their 
lamellarity and size (78-80). It is important to keep in mind that the size of the 
vesicle will determine bilayer curvature and can affect enzymatic reactions and 
lateral diffusion (81-83), lipid miscibility and thermotropic behavior (84-87). The 
vesicles in this thesis were generally 100 to 200 nm in diameter (GUVs being an 
exception with µm size) and thus the local membrane curvature experienced by 
the lipids is relatively low. 
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2.5. Membrane properties of cholesterol 
2.5.1. Sphingomyelin-cholesterol interactions 
As already mentioned, cholesterol is able to increase the acyl chain order in the 
Ld phase and decrease it in the Lβ phase, creating what is known as the Lo phase. 
This property of cholesterol is vital, enabling mammalian cells to regulate 
membrane thickness, fluidity and leakage and also makes the membrane 
stronger and resistant to osmotic pressure (88-91). Although it is almost 
impossible to directly image Lo domains in living cells because of the size of the 
domains and their dynamic nature, there are indirect proof of the possible 
interactions between sphingolipids and cholesterol. Cholesterol and SM 
distribution in cells correlate (69) and it has been observed that plasma 
membrane SM levels affect both the distribution and de novo synthesis of 
cholesterol (92;93). It has been proposed that sphingolipid-cholesterol lateral 
microdomains, also containing particular proteins, are formed on the membrane 
of cellular organelles from where they then bud off to form transport vesicles 
heading for the plasma membrane (38;39;94;95). Indeed, secretory vesicles 
enriched in cholesterol and sphingolipids has been observed to bud off from the 
trans-Golgi network destined for the plasma membrane (96). A recent definition 
of membrane rafts stipulates that they are “small (10-200 nm), heterogeneous, 
highly dynamic, sterol- and sphingolipid-enriched domains that 
compartmentalize cellular processes” (97). Rafts are thought to be involved in 
cell signaling, cell recognition, apoptosis and endocytosis and are implicated in 
many diseases (39;98-100). In recent years, scientist have been able to make the 
first direct observations of sphingolipid-cholesterol microdomains in the plasma 
membrane of living cells (101). By combining the high temporal resolution of 
fluorescence correlation spectroscopy (FCS) and high nanoscopic resolution of 
stimulated emission depletion (STED) it was shown that fluorescently labeled 
sphingolipids and glycosylphosphatidylinositol anchors in the bilayer were 
hindered in their motions in a cholesterol concentration dependent manner (101).  
In model membranes it is possible to observe Lo domains of cholesterol and SM. 
The reason for this interaction is not yet fully understood. The superior hydrogen 
bonding properties of SM compared to other lipid classes (see Section 2.2.2) and 
the presence of a hydrogen bond donor (hydroxyl group) in cholesterol has 
suggested that a direct hydrogen bond link between the C3 hydroxyl group of 
SM and the hydroxyl group of cholesterol exists (16;102;103). IR and monolayer 
studies on SM analogs with modified functional groups affecting hydrogen 
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bonding have, however, indicated that the amine group of SM is of greater 
importance for SM/Chol interactions than the C3 hydroxyl group (104-107). 
Molecular dynamics (MD) simulations in binary systems support a direct 
SM/Chol hydrogen bonding (108-110) but in ternary systems where POPC is 
added such hydrogen bonds can no longer be observed (111). What is observed 
however is the formation of charge pairs between the hydroxyl group of 
cholesterol and the positive charge in the choline group of SM (109;111). The 
head group of PSM also tilts down perpendicular to the bilayer normal, which 
was more than observed for 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
(DPPC) (112). The tilt increased with the effective head group surface area and 
may help SM shield cholesterol from unfavorable interactions with water 
molecules, a phenomenon known as the umbrella effect (113). The umbrella 
effect may be at least partially the reason for SM-Chol interactions.  
As mentioned in Section 2.4.3. the presence of double bonds and methyl 
branches in the N-linked acyl chain decreases the interactions between SM and 
cholesterol (55-62) as indicated by that the thermal stability and sterol content of 
the sterol-rich domains decrease if unsaturation and branching is increased 
(114;115). This is true for both SM and PC. Methyl branches display the greatest 
effect if they are in the center of the acyl chain or close to the interphase, while 
methyl groups at the end of acyl chains have little effect on SM/Chol interactions 
(116). The lipid head group and electrostatics also have a large effect on sterol 
interactions. A lipid with a large head group, e.g. PC or SM solubilizes more 
cholesterol than a lipid with a smaller head group, such as PE or N-palmitoyl 
ceramide phosphoethanolamine (72;117). This could be explained by the 
umbrella model mentioned earlier. Studies in bilayer vesicles have shown that 
SM has the highest affinity for cholesterol, followed by PS > PC > PE (75). 
Monolayer studies contradict these findings having the lipid species in the order 
SM > PC > PS ≈ PE (118), perhaps a more logical order, since SM and PC shares 
the same head group structure. Unpublished work from our group has shown 
that both SM and PC do form sterol rich domains whereas PS failed to do so, 
indicating that PC is a better partner for cholesterol in the Lo phase compared to 
PS. The difference between SM and PC can be explained by the difference in 
head group tilting causing the effective head group area to be larger for SM (119). 
Although the results are still not solid for all the lipid species SM always displays 
the highest affinity for cholesterol. The varying results obtained in different 
studies show that the sterol interactions with phospholipids depend on many 
modes of interaction and involve several structural elements. The contribution of 
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each structural element also depends on the contribution of the other elements, 
the adjacent molecular structures and the environment.  
2.5.2. Structural modifications of cholesterol 
A number of studies have been carried out to try to resolve which functional 
groups of cholesterol give it its membrane properties. The planar ring system 
(120), an acyl chain with similar structure to that of cholesterol (121;122) and the 
hydroxyl group in the β position at C3 (123-125) are all properties that have been 
deemed important for proper membrane function. These studies have all been 
done using sterols present in small amounts in cells; precursors or degradation 
products of some sterol synthesis pathway, and their membrane properties, such 
as effects on membrane permeability, have been examined and compared to 
those of cholesterol. The structure of the surrounding lipids will also be of 
importance and many studies about how the structure of the phospholipids and 
sphingolipids affect interactions with cholesterol have been carried out.  
A number of naturally occurring 3β-analogs of cholesterol is present as 
intermediates in sterol synthesis or as sterol degredation products. The epimer of 
3β-cholesterol, 3α-cholesterol or epicholesterol, is a rare cholesterol species in 
nature. Although structurally differing only in the stereochemistry of the C3 
carbon the two epimeres have markedly different membrane properties (126). 
Thus, replacing cholesterol with epicholesterol will inhibit cell growth and 
survival (127). The altered stereochemistry will also lead to a change in 
membrane location. MD studies of 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC) bilayers showed that the OH of epicholesterol is located near the 
phosphate head group of a DMPC molecule whereas the OH of cholesterol was 
located close to the ester carbonyl groups (128). Studies on pure epicholesterol 
monolayers have shown that it occupies a larger cross-section area and has a 
reduced collapse pressure compared to cholesterol (129;130). It is also less 
effective in condensing saturated PC monolayers (131). Reduction of enthalpy 
and cooperativity of the gel-liquid crystalline phase transition of PC bilayers 
observed with the addition of cholesterol was observed to be less obvious when 
epicholesterol was used instead of cholesterol (126;132).2H-NMR studies have 
also indicated that epicholesterol is less effective in ordering the acyl chains of 
saturated PCs than cholesterol (133). However, C13-NMR and ESR spectroscopy 
studies on unsaturated PCs showed no difference in the ordering effects of the 
two sterols (134-136). Epicholesterol has also been shown to be less effective in 
decreasing the passive permeability of PC bilayers than cholesterol (137;138). The 
17 
 
flip-flop rate of epicholesterol between the leaflets of a PC bilayer is also much 
faster than cholesterol (139;140). Despite these differences, the Lo domain 
forming properties of epicholesterol is rather similar to those of cholesterol (141).  
Oxidation of the sterol 3-OH group yields cholest-5-en-3-one or 3-keto-
cholesterol. Studies regarding membrane properties of this cholesterol metabolite 
are not as extensive as those regarding epicholesterol. In pure monolayers 3-keto-
cholesterol occupies a cross-section area similar to that of cholesterol (142). The 
collapse pressure of a 3-keto-cholesterol monolayer is however much lower than 
that of cholesterol (142). The condensing effect in sterol/DPPC monolayers is also 
somewhat lower for 3-keto-cholesterol (143) while in sterol/POPC monolayers 
the two sterols display a similar condensing effect (142). MD calculations have 
indicated that 3-keto-cholesterol is somewhat less effective in increasing the acyl 
chain order and the membrane thickness of a DPPC bilayer than cholesterol 
(144). The 3-keto-cholesterol is less polar than cholesterol, leading to an increase 
in the tilt angle and in the rate of motion in bilayers (144). 3-keto-cholesterol will 
also penetrate deeper into a DPPC bilayer and, unlike most other sterols studied, 
it occasionally enters the hydrocarbon core of the bilayer and flip-flop to the 
other leaflet (144).  
3-keto-cholesterol can be further methylated or ethylated to form cholesteryl 
methyl ether and cholesteryl ethyl ether respectively. Both of these sterols are 
able to condense the packing in 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine 
(DOPC) membranes (129). Cholesteryl methyl ether can also support the growth 
of Mycoplasma capricolum in the absence of cholesterol (145). Cholesterol can also 
be acetylated forming cholesteryl acetate, whose membrane condensing e is only 
marginal compared to the ether analogs (129). It is however capable of sustaining 
the growth of M. capricolum (145). Other studied natural 3β analogs of cholesterol 
are for example cholesterol sulfate, a negatively charged cholesterol analog 
present in several human tissue types (146).  
2.6. Ceramide as a bioactive molecule 
2.6.1. The formation of ceramide rich signaling platforms 
Ceramide is both a structural element of cellular membranes as well as an 
important molecule in cell signaling events. Ceramides have for example been 
shown to affect cell proliferation, differentiation, migration and apoptosis (147-
150). The structure of ceramide determines its membrane properties. The 
saturated acyl chains of ceramide form strong van der Waals interactions with 
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saturated neighboring lipids and the sphingosine back bone can act as both a 
hydrogen bond donor and acceptor. The double bond between C4 and C5 has 
also been shown to be important for the membrane packing of ceramides (151). 
Although little direct evidence of inter-lipid hydrogen bonds between ceramides 
and other lipids exist, it is known that ceramides form hydrogen bonds to 
neighboring ceramides. Shah et al. were the first to suggest such hydrogen bond 
patterns (152). Using DSC and X-ray diffraction they proposed that the hydroxyl 
hydrogen of a ceramide hydrogen bonded with the amide of an another 
ceramide (152). A more recent study proposed that the hydroxyl hydrogen 
would bond to the carbonyl oxygen instead of the amide (153). Ceramides can be 
generated by de novo synthesis, by a salvage pathway or SM degradation by 
sphingomyelinase (SMase). Out of these the one mostly used by cells in quickly 
generating larger quantities of ceramide is degradation of SM by SMase. When 
composed of POPC/PSM were treated with SMase the acyl chain order increased 
followed by a slower formation of ceramide rich gel domains (154). When 
cholesterol was added to the vesicles presence of phase separation enhanced the 
SMase activity and that the cholesterol displacement by the ceramide formed 
only took place at lower cholesterol concentrations (155). 
The structural properties of ceramide make it very hydrophobic. It has a high Tm 
and a restricted miscibility with other lipids (156-159). Ceramide impose negative 
membrane curvature and thus curvature stress in bilayer membranes (for more 
details see section 2.4.1.). Addition of ceramide to a phospholipid bilayer 
increases the order of the lipid acyl chains similarly to the effects seen with 
addition of cholesterol (160-162). Ceramide has also been shown to, under certain 
conditions, displace cholesterol from SM/Chol rich ordered domains to form 
SM/ceramide rich gel domains (163).  
Ceramides can also induce the formation of lateral microdomains without SM 
(164). Such domains are thought to play a role as signaling platforms. Increase in 
ceramide content in the membrane could lead to the formation of small 
ceramide-rich domains that could then cluster together and form larger 
assemblies (165) leading to a spatial and temporal reorganization of membrane 
components including receptors and signaling molecules and thus facilitating the 
signal transduction (166). Ceramide may not only facilitate formation of a 
platform were signaling molecules can cluster but it can also recruit molecules to 
transfer the signal by interacting with the activated receptor as well as exclude 
unwanted molecules that would interfere with the signal transduction (166). The 
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tight packing of ceramide rich domains might also help to stabilize large 
signaling complexes so that the signal can be properly transducted trough the 
membrane (166). The most studied case of ceramide platform signal transduction 
is the clustering and activation of cell death receptors such as Fas/CD95 and 
CD40 (167-169;169;169-173). Ceramide-rich domains have also been implicated in 
infections by bacteria and viruses (174-178), bacterial mediated hot-cold 
hemolysis (179), the death of cancer cells by anti-tumor drugs and radiation (180-
183) as well as in control of intracellular traffic (184;185). There is also evidence 
from both model and natural membrane studies that ceramide is able form well 
organized transmembrane channels to accommodate protein and ion diffusion 
(186;187). Long chained ceramides (C24-Cer) have also been shown to form 
tubular structures when mixed with POPC in giant unilamellar vesicles (188;189).  
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3. AIMS OF THE STUDIES 
The main aims of the studies presented in this thesis were to investigate how 
cholesterol interacts with membrane phospholipids and to understand some of 
the structural features of both the lipids and cholesterol that modulate these 
interactions. We also studied a new ceramide delivery system for cultured cells. 
The specific aims of each paper are listed below. 
In paper I the aim was to study if the acyl chain order of SM and PC lipids has an 
effect on sterol bilayer affinity. The acyl chain order of 14:0-SM versus 14:0/14:0-
PC, 14:0/15:0-PC or 15:0/14:0-PC was determined using fluorescence 
spectroscopy and NMR. Partitioning of the fluorescent probe cholestatrienol was 
also measured with single component bilayers. The order and partitioning data 
were combined in order to determine if the acyl chain order had an effect on the 
sterol bilayer affinity. 
In paper II the aim was to compare the effects of cholesterol and the cholesterol 
analog, aminocholesterol in order to see how the partial positive charge on 
aminocholesterol affects sterol bilayer behavior. We measured the phospholipid 
acyl chain order, bilayer lateral domain formation, liquid-ordered domain 
formation and detergent solubilization protection of both sterols in model 
membranes.  
In paper III the aim was to study the biophysical properties of the cholesterol, 
Chol-PC, in binary and ternary bilayer systems in order to obtain more 
information about how the sterol shape affects bilayer properties. We examined 
the interactions of Chol-PC with both saturated and unsaturated ceramides as 
well as saturated and unsaturated phospholipids to determine how the large 
phosphocholine (PC) head group affects sterol behavior.  
In paper IV the aim was to compare the availability of N-hexanoyl ceramide (C6-
Cer) to  HeLa and rat thyroid FRTL-5 cells when presented either in DMSO as a 
Chol-PC/C6-Cer lipid complex. Ceramide uptake and effects on cell proliferation, 
apoptosis and Ca2+ homeostasis were used as indicators of C6-Cer transfer into 
cells.  
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4. MATERIALS AND METHODS 
Here follows a brief description of the methods used in our studies. This chapter 
is only meant as an overview and a more detailed description of the methods 
used can be found in the original publications. Papers I, II and III contain only 
model system studies whereas paper IV is focused on studies in cultured cells. 
 
Table 1. List of methods involved in the original papers I-IV 
 
Paper 
Technique I II III IV 
c-Laurdan emission  
x x 
 
Fluorescence Anisotropy x x x  
Fluorescence Quenching  
x x 
 
Fluorescence Lifetime  
x x 
 
Sterol Partitioning x    
Differential Scanning Calorimetry 
 
x x 
 
Nuclear Magnetic Resonance x 
   
Cell Culture    
x 
TLC   
x x 
 
4.1. Materials 
Lipids and lipid precursors used in the studies were purchased from Avanti 
Polar Lipids (Alabaster, Al, USA), Sigma-Aldrich (St Louis, MO, USA) and 
Molecular Probes (Leiden, the Netherlands) and used without further 
purification. In paper I all the lipids used were synthesized in-house according to 
standard protocols (66;190) using the coupling of lyso-SM or lyso-PC to selected 
fatty acids. c-Laurdan was kindly provided by Professor Bong Rea Cho 
(Department of Chemistry and Centre for Electro- and Photo-Responsive 
Molecules, Korea University, Seoul, Korea), synthesized according to (191). PSM 
was purified from egg yolk SM (Avanti Polar Lipids) using reverse phase HPLC 
(116). The fluorescent probes cholestatrienol (CTL) and trans-parinaric acid (tPa) 
were synthesized in-house (192;193). The source of other chemicals and 
molecules used in the experiments can be found in the original publications (I-
IV). 
22 
 
4.2. Vesicle preparation 
In all of the papers synthetically prepared model membrane vesicles of known 
lipid composition was used. In brief, the desired lipids and fluorophores were 
mixed at indicated concentrations from organic solvent stock solutions and then 
dried under a stream of nitrogen at 40 °C. To insure proper mixing the formed 
lipid film was then re-dissolved in chloroform and dried again. The lipid films 
were then hydrated in buffer or milli-Q water (final lipid concentration 50 or 100 
µM, see figure legends) at a temperature higher than the Tm for the highest 
melting lipid species (typically 55-65 °C) to create multilamellar vesicles (MLVs). 
To produce more uniformly sized MLVs (all experiments except CTL 
partitioning and LUV size measurements, papers I and II respectively) the 
solution was sonicated in a Bransonic 2510 (Branson Ultrasonics, Danbury, CT) 
bath sonicator for 5-10 min at T > Tm. For the experiments requiring large 
unilamellar vesicles, LUVs, (CTL partitioning and LUV size measurements, 
papers I and II) the hydrated solutions were extruded (at T > Tm) through a 200 
nm membrane filter to form LUVs. All vesicle solutions were used within 48h of 
preparation.  
4.3. Fluorescence spectroscopy 
4.3.1. c-Laurdan emission 
To determine the degree of hydration in the bilayer interface (paper II) we used 
c-laurdan emission measurements. The emission spectra for c-laurdan were 
measured at the indicated temperatures in MLVs (total lipid concentration 50 
µM, c-laurdan present at 1 mol%). The excitation was set to 365 nm and emission 
spectra recorded between 400 and 550 nm. From the data a generalized 
polarization value (GP-value) vas calculated according to: (I440 – I480 nm) / (I440 + 
I480 nm). 
4.3.2. Fluorescence anisotropy 
To study acyl chain order, steady-state fluorescence anisotropy measurements 
were performed in MLVs using the fluorophore diphenylhexatriene, DPH (194). 
Samples containing 1 nmol of DPH and 100 nmol of lipid were hydrated in 2 ml 
of milli-Q water or buffer (final lipid concentration 50 µM) and sonicated to 
create MLVs. The fluorescence intensity was recorded as a function of 
temperature on a PTI Quanta-Master spectrofluorimeter (Photon Technology 
International, Lawrenceville, NJ) operating in the T-format. Temperature was 
increased at a rate of 2 °C/min and the wavelengths used were 360 nm for 
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excitation and 430 nm for emission. The G-factor was determined prior to each 
measurement and the measured emission intensity was converted to anisotropy 
using the FeliX32-software according the formula described in (195). 
4.3.3. Fluorescence quenching 
To obtain information about domain thermostability quenching of the ordered 
domain fluorophore trans-parinaric acid, tPa by the quencher 7SLPC was 
performed. MLVs at a final lipid concentration of 50 µM were prepared in milli-
Q water or buffer in sets of two; the quenched sample and the non-quenched 
sample. The quenched F-sample contained both tPa at 1mol% and 7SLPC, 
replacing half of the disordered lipid POPC that was used as the bulk lipid in 
these experiments. The non-quenched F0-sample contained only tPa (1mol %). 
The fluorescent emission for both samples was recorded on a PTI Quanta-Master 
spectrofluorimeter as a function of temperature. Excitation was set at 305 nm and 
emission at 405 nm and the temperature was ramped at 5 °C/min. The emission 
intensity was combined as F/F0 (using FeliX32-software), giving the fraction of 
non-quenched tPa and plotted against temperature. 
4.3.4. Fluorescence lifetime 
To obtain information about the degree of order in our model bilayer systems we 
measured the time-resolved fluorescence decays of the fluorophore tPa. MLVs 
containing 1 mol% of tPa were prepared to a final lipid concentration of 100 µM. 
The fluorophore was excited using a 298 nm PLS300 led laser source and the 
emission data collected at 405 nm using a FluoTime 200/ PicoHarp 300E TCSPC 
time-resolved spectrofluorimeter (PicoQuant GmbH, Berlin, Germany). The 
obtained data was fitted with a non-linear least squares iterative reconvolution 
method, based on the Marquardt-Levenberg algorithm, to obtain the decays. The 
reduced χ2 and the random distribution of the weighted residuals were used as 
justification for the number of exponentials. 
4.3.5 Sterol partitioning 
To determine the sterol affinity for PC and SM bilayers we measured the 
distribution of CTL between methyl-β-cyclodextrin (Sigma Chemicals, St. Louis, 
MO) and large unilamellar phospholipid vesicles according to Nyholm et al. 
(196). Briefly, a buffer solution of LUVs containing the fluorophore is subjected to 
increasing concentrations of mβCD and the anisotropy of CTL is monitored. 
From the anisotropy values it is then possible to calculate the amount of CTL left 
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in the vesicles and further processing of the values yield the molar fraction 
partition coefficient, Kx, for CTL, a high value indicating strong affinity. 
4.4. Differential scanning calorimetry (DSC) 
To study the thermotropic properties of SM and PC bilayers with added sterol 
derivatives we performed DSC analysis on fully hydrated bilayers (composition 
as stated in papers II and III). The measurements were performed on a 
Calorimetry Sciences Cooperation Nano II DSC (Provo, UT) and the data was 
analyzed using CpCalc (CSC, Provo, UT) and Origin 7 (Microcal, Northampton, 
MA). At least two consecutive heating/cooling scans (0 to 80 °C, rate 1 °C/min) 
were performed for all samples. 
4.5. Nuclear magnetic resonance (NMR) 
The NMR experiments in paper I were performed at the University in Utrecht, 
The Netherlands, by Jacques P.F. Doux and J. Antoinette Killian. These 
experiments were done with two deuterium labeled molecules 14:0/14:0(d27)-PC 
and 14:0(d27)-SM prepared in our lab (for detailed synthesis protocol se paper I, 
Materials and Methods). Two to three milligrams of either lipid was dissolved in 
deuterium free water and hydrated for 3 hours at 40 °C. After this the samples 
were freeze-thawn three times and moved to 4mm o.d. ZrO2 NMR tubes and 
sealed with Kel-F. The NMR measurements were performed with a wide-bore 
11.7 T Ultrashield magnet (Bruker Biospin, Billerica, MA, USA) equipped with an 
Advanced III consol (Bruker, Biospin).  
4.5. Cell culture  
For the cell experiments in paper IV two cell types were used: Rat thyroid FRTL-
5 cells (Interhyr Foundation, Bethesda, MD) and HeLa cells. The FRTL-5 cells 
were grown in Coon’s modified Ham’s F12 medium supplemented with 5% calf 
serum and six hormones in a water saturated atmosphere of 5% CO2 and 95% air 
at 37 °C (197) and HeLa cells in Dulbecco’s Modified Eagle Medium 
supplemented with fetal bovine serum (10%), L-glutamine (1%) and penicillin-
streptomycin (1%) at 37 °C and 5% CO2. For further reference regarding the 
performed cell experiments ([3H] labeling, thymidine incorporation, cell 
counting, cytosolic Ca2+ measurements, mitochondrial Ca2+ measurements and 
FACS) please see the Experimental section in paper IV. 
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4.5.1. Thin layer chromatography (TLC) 
To study [3H]-C6-Cer incorporation in HeLa and FRTL-5 cells cellular lipid 
content was analyzed by TLC. Lipids were extracted using hexane followed by 
solvent evaporation. After the evaporation the samples were dissolved in 
hexane/isopropanol for application onto a TLC plate (TLC PE SIL G Flexiplate, 
Whatman Ltd, Maidstone, Kent, England). Standard lipids were co-eluted 
together with the cell samples. After elution the spots were dried and visualized 
using iodine vapor. The desired spots were cut out and placed in scintillator 
tubes together with 3 ml of scintillator fluid (Optiphase 3, PerkinElmer/Wallac, 
Turku, Finland) and incubated over night. The next day radioactivity was 
counted with a LKB Wallac 1216 Rackbeta liquid scintillator counter (Wallac Oy, 
Turku, Finland).   
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5. RESULTS 
5.1. Effect of acyl chain order on cholesterol partitioning 
Cholesterol is an important membrane fluidity regulator but it does not interact 
equally well with all membrane lipids (6;65;118;198-200). For example, given a 
choice between saturated and unsaturated phospholipids it will prefer the 
saturated ones (65;200). The most abundant saturated phospholipid in biological 
membranes is SM with a long chain base and an N-linked saturated or 
monounsaturated C16-24 long acyl chain (201). SM and PC share the same head 
group but the interface region is different. SMs have more possibilities to form 
hydrogen bonds compared to PCs. When comparing acyl chain matched PCs and 
SMs, cholesterol will partition with SM (66;200;202). The reason for this is not 
fully understood. NMR and MD studies indicate that although important for 
SM/SM interactions, hydrogen bonding seems not to play a role in SM/Chol 
interactions (203;204). Another reason has been thought to be the difference in 
acyl chain order. NMR and MD studies of DPPC and PSM bilayers have shown 
that although these two lipids have an almost identical acyl chain structure and 
transition temperature, their acyl chain order profiles are markedly different, that 
of SM being more ordered (17;205). It was therefore of importance to investigate 
how much the difference in acyl chain order is affecting sterol partitioning 
behavior. To determine this we investigated the partitioning of the fluorescent 
cholesterol analog cholestatrienol in membranes composed of myristoyl SM and 
corresponding PCs under fluid conditions. 
5.1.1. The effect of temperature on the acyl chain order  
Because of the temperature sensitivity of the probe used (CTL) the lipids were 
chosen so that they were fluid below ~45 °C (the upper limit for reliable CTL 
measurements). Because of this limitation we used 14:0-SM which has a Tm of ~24 
°C (54). The chain matched PCs, 14:0/14:0-PC, 14:0/15:0-PC and 15:0/14:0-PC have 
Tm of 27, 32 and 31 °C respectively. Since the sn-1 chain and the long chain base 
of SM are not identical in length we chose to include PCs with a moderately 
longer acyl chain both in the sn-1 and sn-2 position to see if this had any affect. 
To determine the relative acyl chain order of these different lipids in the fluid 
phase we measured the DPH anisotropy at the temperatures indicated in Fig. 7. 
As expected, 14:0-SM showed the highest degree of order whereas 14:0/14:0-PC 
showed the highest degree of disorder, the other two PCs giving intermediate 
values (Fig. 7). Such a difference has been shown previously for other acyl chain 
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lengths and can be explained by the difference in hydrogen bonding properties 
between SM and PC (103;206). 
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Figure 7. DPH Anisotropy in pure phospholipid bilayers. Steady-state anisotropy was 
recorded as a function of temperature for bilayers of the indicated lipids. Each value is the 
average of 2-3 different measurements (mean ± SEM), the lines are polynomial fits to the 
data. The figure is adapted from paper I with permission of Cell Press. 
 
The acyl chain order was also measured by a more direct method, 2H-NMR 
spectra were measured for perdeuterated tetradecanoate (d27) acyl chains linked 
to the N- or sn-2-position in SM and PC, respectively. This technique allowed for 
measurements in a pure SM or PC membrane without the addition of probes, 
and it also provides a more detailed view for the individual acyl chain segments 
than DPH which only reported an average chain order. The measured spectra 
were deconvoluted using dePaking algorithms (207-209) and from these spectra 
the order parameter for the acyl chain carbons were obtained (Fig. 3 paper I). For 
the 14:0-PC carbons 2-8 had no difference in the order profile, only more distant 
carbons experienced more disorder, consistent with previous studies (210;211). 
For SM no clear plateau was detected, instead the order parameter decreased 
with decreasing distance from the interface. The average acyl chain order 
parameter reported by NMR was calculated for carbons 2-8 for PC and 3-8 for 
SM since these segments are the ones most likely to interact with cholesterol (Fig. 
8). The NMR results were in agreement with the DPH anisotropy data, i.e. 
showed a higher order for SM versus PC and displaying the same temperature 
dependence (lower order at higher temperatures). 
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Figure 8. Average deuterium order parameter (SCD) as a function of temperature. The 
average order parameter was calculated for acyl carbons 2-8 in 14:0/14:0-PC and 3-8 in 
14:0-SM. The lines are polynomial fits and given for visual aid. The figure is adapted 
from paper I with permission of Cell Press. 
 
5.1.2. Equilibrium partitioning of cholestatrienol 
To determine how the PC or SM acyl chain order affects the CTL partitioning 
coefficient, Kx, the partitioning of CTL between unilamellar LUVs and methyl-β-
cyclodextrin was measured (see Materials and Methods section). The 
measurements were performed at the same temperatures as the DPH and NMR 
measurements for each lipid and the obtained CTL partitioning values were 
correlated with the DPH anisotropy data (Fig. 9A). As evident from the graph 
there was a significant difference between PC and SM in the affinity of CTL for 
the bilayer, even at equal acyl chain order. The difference also became larger as 
the bilayer order was increased (temperature lowered). Since CTL is more 
restricted in its movements and resides closer to the interface in the bilayer 
compared to DPH it was of importance to also measure CTL anisotropy and 
correlate these values with the partitioning data. Data in Figure 9B differed only 
moderately from figure 9A indicating that even when the probe was different the 
affinity of CTL was higher for SM than PC. The partitioning data was also 
plotted against the 2H-NMR data and the same trend was observed (Fig. 6 in 
paper I). 
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Figure 9. CTL partitioning into phospholipid bilayers plotted against DPH (A) or CTL 
anisotropy (B). Kx value of CTL is plotted against DPH or CTL anisotropy. Each value is 
the average of 2-3 measurements ±SEM. Linear regression fits are added for visual aid. 
The figure is adapted from paper I with permission of Cell Press. 
 
5.2. Membrane properties of a positively charged sterol 
 Sterols are important constituents in cell membranes of most eukaryotic cells. 
The sterol structure has been well conserved through evolution and only a few 
sterol species are found among the diversity of eukaryotic cells (212-214). 
Cholesterol, the main mammalian sterol, is an important modulator of cellular 
lipid bilayers where it can eliminate densely packed gel phases as well as 
increase the acyl chain order of loosely packed membranes (215;216). The 
changes in membrane fluidity and thickness caused by cholesterol can also help 
modulate the function of membrane proteins (217). The β-hydroxyl group on 
carbon 3, a planar ring sterol skeleton with the two protruding methyl groups, a 
double bond at Δ5 and an iso-octyl side chain are all important for the proper 
membrane functions of cholesterol, and studies were these molecular structures 
are altered have shown considerate effects on membrane structure and function 
(123-125;218-221). Apart from cholesterol, some cells also contain cholesterol 
sulfate, a negatively charged sterol with a sulfate group at the 3 carbon (222). 
Cholesterol sulfate is present only in trace amounts in most cells but has been 
shown to protect red blood cells against hypotonic hemolysis and to decrease the 
fertilization efficiency of sperm (222). 3β-amino-5-cholestene is a synthetic sterol 
with an amino group on the 3 carbon, with a partial positive charge (pH 
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dependent). Although cationic lipids are not found in eukaryotic cells they have 
been successfully used in biotechnical applications, e.g. to complex DNA with 
lipids to obtain transfection competent DNA/lipid lipoplexes (223). Cationic 
sterols have been shown to be promising transfection agents as well as having 
antimicrobial effects (224-226). It was therefore of interest to study how 
aminocholesterol behaves in bilayer membranes. 
5.2.1. Ordering of phospholipid acyl chains by sterols 
To study the ordering effect of cholesterol or aminocholesterol on PSM and 
DPPC bilayers in the liquid crystalline phase we measured the anisotropy of 
DPH in those bilayers (Fig. 11). As evident from paper I, the anisotropy function 
correlated well with the relative deuterium order profile obtained from 2H-NMR 
measurements and DPH anisotropy can therefore be considered a valuable tool 
in determining acyl chain order. Our results showed that both sterols were able 
to increase the order of the liquid crystalline phase of PSM equally, and that the 
increased order was concentration dependent (Fig. 11A and B). Also for DPPC an 
increased order was seen albeit aminocholesterol was less effective than 
cholesterol (Fig. 11 C and D). These results indicate that both sterols are able to 
order the acyl chains of PSM and DPPC in the liquid crystalline phase, forming a 
liquid ordered phase. 
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Figure 11. Steady-state DPH anisotropy in PSM (panels A and B) and DPPC (panels C 
and D) with increasing amounts of cholesterol (panel A and C) or aminocholesterol 
(panel B and D) at the indicated concentrations. Total phospholipid concentration was 50 
µM and DPH present at 1 mol%. Temperature was ramped 5 °C/min and data are 
representative from three experiments. The figure is adapted from paper II with 
permission of ACS Publications. 
 
5.2.2. Differential scanning calorimetry thermograms of binary 
phospholipid/sterol bilayers 
To further investigate the effect of aminocholesterol on PSM and DPPC bilayers 
we employed DSC to determine the enthalpy of gel phase melting and 
cooperativity (Fig. 12). Cholesterol is known to reduce the enthalpy of Tm in a 
concentration-dependent manner (227) and we investigated if aminocholesterol 
acts analogously. Multilamellar vesicles of either PSM or DPPC with an 
increasing amount of aminocholesterol showed that already 5 mol% of the sterol 
was able to remove the pre-transition of both bilayers and reduce the gel to 
liquid transition enthalpy (Fig. 12). Tm was also shifted to lower values. For PSM, 
a two component melting was observed, a more cooperative one at 39.9 °C and a 
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less cooperative one at 40.4 °C (Fig. 12). With DPPC a more symmetric transition 
was observed at 40.5 °C (Fig. 12). Similar results were obtained when the sterol 
concentration was increased to 10 mol% and at 20 mol% both bilayers displayed 
a broad, low-enthalpy transition. The enthalpy decreased almost linearly with 
increasing sterol concentration, approaching zero at 30 mol% of aminocholesterol 
(Fig. 12).  
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Figure 12. DSC thermograms of PSM (left) and DPPC (right) in the presence of the 
indicated aminocholesterol. The phospholipid concentration was 1 mM and the scanning 
rate was 1 °C/min. The insert displays the calculated molar enthalpies versus 
aminocholesterol concentration. The figure is adapted from paper II with permission of 
ACS Publications. 
 
5.2.3Ordered domain formation in binary and ternary bilayers 
DPH quenching was used to determine the presence and thermostability of the 
ordered domains in binary and ternary bilayers consisting of a disordered lipid, 
(POPC), and an ordered lipid (PSM or DPPC), with added cholesterol or 
aminocholesterol (Fig. 13). DPH partitions evenly between ordered and 
disordered domains whereas the quencher 7SLPC primarily partitions into 
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disordered domains (228). Because of this a fraction of DPH will be protected 
from quenching if ordered domains are present, and the thermostability of these 
domains can be measured. In binary POPC/PSM mixtures, ordered domain 
melting started already at 12 °C and melted completely at 28 °C (Fig. 13, left 
panel). If 10 mol% cholesterol was added the thermostability of the ordered 
domain was markedly increased with the end off melting at approximately 50 
°C. Surprisingly, aminocholesterol failed to affect the thermostability of the PSM 
rich domain. When PSM was replaced by DPPC the thermostability for the 
binary mixture was close to that of PSM but neither of the sterols was able to 
induce any observable change (Fig. 13, right panel).  
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Figure 13. Quenching of DPH fluorescence in ternary bilayers. POPC was present at 60 
mol%, PSM (left panel) or DPPC (right panel) at 30 mol% and the sterol at 10 mol%. 
Curves are representative of at least three different experiments for each composition. The 
figure is adapted from paper II with permission of ACS Publications. 
 
5.2.4. Lifetime analysis of trans-parinaric acid 
In order to further explore the ability of aminocholesterol to form a liquid 
ordered phase we performed lifetime measurements of the probe tPa (Fig. 14). 
Our samples consisted of POPC and PSM or POPC and DPPC with added 
cholesterol or aminocholesterol. The lifetime of tPa is relatively short in fluid 
bilayers and becomes significantly longer if gel phase is present while the 
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lifetime in the liquid ordered phase is intermediate (229). For the POPC/PSM 
mixture the lifetime was ~12.5 ns indicating that PSM was partially mixed with 
POPC (Fig. 14) and not in a gel state (the lifetime for pure PSM in gel phase is ~40 
ns (229)). Addition of cholesterol or aminocholesterol increased the lifetime to 19 
and 16 ns respectively. Since the lifetime of tPa in the liquid ordered phase has 
been determined to be between 15 and 25 ns (229) it is evident that both sterols 
do indeed induce the formation of a liquid ordered phase, aminocholesterol 
being somewhat less effective. When PSM was replaced with DPPC similar 
results were obtained and again aminocholesterol was less ordered than 
cholesterol (Fig. 14).In a binary POPC/DPPC system, however, the tPa lifetime 
was ~34 ns, indicating that POPC was less miscible with DPPC compared to PSM 
and that DPPC was able to form a gel phase.  
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Figure 14. The lifteime of tPa in ternary bilayers. POPC was present at 60 mol%, PSM 
(left panel) and DPPC (right panel) at 30 mol% and the sterol at 10 mol%. Each value is 
the average of three measurements ± SEM. The figure is adapted from paper II with 
permission of ACS Publications. 
 
5.3. Membrane properties of a sterol with a large head group 
The phospholipid head group structure has been shown to be important for 
cholesterol interactions in many studies (118;230). Cholesterol favors lipids with 
large head groups such as phosphocholine(230). Decreasing the head group size 
will decrease the interactions between cholesterol and the SM or the less 
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favorable PC lipid. For example, phosphatidylethanolamines have a markedly 
lower affinity for cholesterol than PCs (230). Also, reducing the PC head group 
size by removal of methyl groups will reduce cholesterol affinity for the bilayer 
(231). The effect of a large head group could be explained by the umbrella model; 
cholesterol has a small head group and needs lipids with larger head groups to 
shield it from unfavorable interactions with water like an umbrella (113;232-234). 
Larger head group lipids also support a higher cholesterol solubility in 
membranes (230).  
Ceramide is a sphingolipid with two free hydroxyl groups, one in the C1 
position and one in the C3 position in the long chain base (235). The hydroxyl in 
the C1 position is an analog to the 3-hydroxyl of cholesterol. Ceramide interacts 
favorably with SM and has been shown, under certain conditions, to displace 
cholesterol from ordered domains indicating that Cer has a higher affinity for SM 
than to cholesterol (26;236;237). Ceramide was also thought to depend on the 
large head group of SM for protection from water and indeed the solubility of 
Cer in SM is very close to that of cholesterol (238). Recent studies have however 
shown that the heads group size of SM is not crucial for Cer interactions (239). 
The main reason for the poor mixing of cholesterol and ceramide has been 
attributed to the small head group size of both lipids and the inability to form 
stable bilayers on their own. However, when ceramide is given a phosphocholine 
head group, becoming a SM, the interactions with cholesterol becomes favored. 
How would the situation be if cholesterol would acquire the head group instead 
of Cer? Previous studies gave some clues to this question, Chol-PC was shown to 
form stable bilayer structures with both dimyristoyl glycerol and cholesterol 
(240). A reasonable continuation to this study was to study the interactions 
between Chol-PC and ceramide. In the following experiments we have studied 
Chol-PC behavior in binary and ternary bilayers and its interactions with 
ceramide and saturated as well as unsaturated phospholipids and cholesterol. 
5.3.1. Formation of vesicles from cholesteryl phosphocholine and colipids 
The first step in the experiments was to test if Chol-PC is indeed capable of 
forming bilayers together with ceramides and cholesterol (240). We prepared 
both giant unilamellar vesicles (GUVs, Fig. 15) using electroformation and large 
unilamellar vesicles (LUVs, Table S1 in paper III) using lipid extrusion. The 
GUVs and LUVs contained an initial 1/1 molar ratio of Chol-PC and either a 
saturated ceramide PCer, an unsaturated ceramide OCer or cholesterol. Because 
of the size of the GUVs we were able to visualize them in a confocal microscope 
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using a bilayer probe (DiI18). We observed that liposomal structures were formed 
(Fig. 15). Many of the vesicles had complex internal structures and the GUVs 
containing PCer were generally smaller than the other two (however, no 
systematic size comparison was performed).  
 
 
Figure 15. Giant vesicles made of a 1/1 molar ratio of Chol-PC and PCer (panels A and 
B), Chol-PC and OCer (panels C and D or Chol-PC and cholesterol (panels E and F). 
Scale bar is 10 µm. The brightness and contrast of the images was slightly improved. The 
figure is adapted from paper III with permission of ACS Publications. 
 
LUVs are too small to be seen in a microscope, but they can be analyzed e.g. 
using light scattering. Size measurements of the different extruded (200 nm) 
compositions showed LUVs with a diameter of 142 nm to 195 nm (SEM ±25 nm) 
with no obvious dependence of size or lipid composition (Table S1 in paper III). 
Besides the 1/1 mixture, also 1/3 and 3/1 ratio mixtures were tested with no 
observable difference in size or lamellarity. Mixtures of 1/1 ratio of Chol-PC/PCer 
and Chol-PC/Chol were highly unilamellar and stable. To further study the 
packing of the bilayers c-laurdan measurements were performed (Fig. 2 in paper 
III). c-Laurdan is sensitive to the hydration level at the interface. Its emission will 
be blue shifted in densely packed domains where the interfacial hydration level 
is low and red-shifted in more loosely packed domains where the interfacial 
hydration level is higher (191). At 20 °C the c-laurdan spectra was observed to be 
blue-shifted at all compositions, in addition, OCer displayed a small red 
shoulder, indicating a higher hydration level (Fig. 2A in paper III). When the 
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temperature was increased to 40 °C the fluorescence of the mixture containing 
Chol-PC and PCer was moderately red-shifted. The fluorescence of the Chol-
PC/OCer mixture was dramatically red shifted and the Chol-PC/Chol was 
unchanged (Fig. 2B in paper III). GP-values calculated from the spectra show 
these values decreased for both PCer and OCer when the temperature was 
increased, whereas that in the Chol-PC/Chol mixture was largely unaffected (Fig 
2C in paper III). Lifetime measurements of the tPa probe showed no clear gel-like 
structures in any of the compositions (Table 1 in paper III). However it showed 
that Chol-PC/OCer and Chol-PC/Chol mixtures had a similar state of acyl chain 
order whereas Chol-PC/PCer had a higher order. 
5.3.2. Properties of bilayers containing cholesteryl phosphocholine 
To investigate the effect of Chol-PC on PSM and DPPC, steady-state DPH 
anisotropy measurements were performed (Fig. 16). The anisotropy of DPH can 
be used as a tool to investigate acyl chain packing since the excited state rotation 
of the molecule will be dependent on the degree of bilayer packing. The results 
showed that Chol-PC was able to destabilize the gel phase of both PSM and 
DPPC which was observed when Chol-PC was substituted by cholesterol (Fig. 
16). This was not surprising since the large head groups of PSM, DPPC and Chol-
PC will lead to packing defects because of the mismatch between the 
hydrophobic volume and the head group volume. A large head groups prevents 
a close packing of the sterol ring of Chol-PC and the acyl chains of PSM and 
DPPC. The ordering of the acyl chains above Tm for PSM and DPPC by Chol-PC 
was also much weaker compared to cholesterol (Fig. 16). To further determine 
how Chol-PC causes gel phase destabilization of PSM and DPPC bilayers, DSC 
measurements were performed (Fig. 4, paper III). Already at 5-10 mol% Chol-PC 
disrupted the gel to liquid crystalline phase transition, e.g. the DSC peaks were 
broadened indicating loss of cooperativity. When Chol-PC was substituted for 
cholesterol the peaks were much narrower, indicating a higher cooperativity 
between the lipid and cholesterol (Fig. 4 in paper III).  
38 
 
Temperature [°C]
10 30 50 70
S
te
ad
y
-s
ta
te
 D
P
H
 a
n
is
o
tr
o
p
y
0,1
0,2
0,3
0,4
0% CholPC
10% CholPC
20% CholPC
30% CholPC
A
Temperature [°C]
0 20 40 60 80
A
n
is
o
tr
o
p
y
0,1
0,2
0,3
0,4
0% CholPC
10% CholPC
20% ColhPC 30% CholPC
B
 
Figure 16. Steady state anisotropy of DPH in PSM (A) and DPPC (B) bilayers with 
increasing amounts of Chol-PC. Lipid concentration was 50 µM and DPH present at 1 
mol%. Temperature was ramped 1 °C/min. The scans are representative of at least three 
different experiments. The figure is adapted from paper III with permission of ACS 
Publications. 
 
Cholesterol is known to order the acyl chains of phospholipids in the liquid 
crystalline state.  In our experiments Chol-PC failed to increase the order of PSM 
and DPPC bilayers (Fig. 16). To compare how the position of the head group 
affects the acyl chain order steady-state DPH anisotropy in equimolar mixtures 
of either PSM/Chol or PCer/Chol-PC was measured (Fig. 6 in paper III). The 
results revealed a higher order for the PSM/Chol system compared to PCer/Chol-
PC indicating that placing the phosphocholine head group on the sphingolipid 
improved the acyl chain packing compared to having it on the sterol. The 
anisotropy results were confirmed with tPa lifetime measurements showing that 
the lateral packing density was higher for PSM/Chol than PCer/Chol-PC bilayers 
(Table 2 in paper III).  
5.3.3. Ordered domain formation in ternary bilayers 
To investigate how Chol-PC behaves in more complex systems we prepared 
ternary mixtures containing POPC, PCer, cholesterol and Chol-PC in different 
combinations and measured the ordered domain stability using tPa (Fig. 17). 
Since PCer is poorly miscible with POPC, it will form ceramide rich ordered 
domains to which also tPa will partition thereby escaping quenching by the 
quencher 7SLPC (that preferably partitions into disordered domains). As 
temperature increases the ordered domains melt and quenching becomes more 
efficient. For PCer rich domains this happened at 35-36 °C (Fig. 17). If cholesterol 
was added in equimolar amounts to PCer the domains thermostability decreased 
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to 28-29 °C. This drop was probably caused both by destabilization of the PCer 
domains by cholesterol and the ordering effect of cholesterol on the bilayer. 
Interestingly, Chol-PC behaved as cholesterol, i.e. lowering the thermostability 
similarly (Fig. 17). If cholesterol and Chol-PC were mixed in equimolar amounts 
with POPC, no ordered domains reported by tPa were detected. Lifetime 
measurements on tPa in identical systems were in good agreement with the 
quenching results, i.e. showed the same τavg. for PCer/Chol and PCer/Chol-PC 
domains and a markedly lower τavg. for Chol/Chol-PC domains (Table 3 in paper 
III).  
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Figure 17. Ordered domains in POPC bilayers measured as by tPa quenching. POPC 
was present at 85 mol% in the F0 sample and in the F sample 30 mol% was replaced by 
the quencher 7SLPC. PCer and sterols were present at 15 mol% and quencher at 1 mol%. 
All curves are representative of at least three different experiments. The figure is adapted 
from paper III with permission of ACS Publications. 
 
5.3.4. Trans-parinaric acid lifetime in ternary bilayers as a function of sterol 
content 
The addition of cholesterol to bilayers composed of POPC and PSM or DPPC 
induces a liquid ordered phase at sufficient cholesterol concentrations (63;229). 
The formation of the ordered phase can be detected using tPa lifetime 
measurements, since tPa preferably partitions into regions of high order where 
the lifetime is significantly higher than in less ordered regions. In a 6/4 molar 
ratio POPC/PSM or POPC/DPPC bilayer addition of 5, 10 and 15 mol% of 
cholesterol induced the Lo phase as evident in Fig. 18. The difference in initial 
lifetime for PSM and DPPC reflects the differences in the gel phase properties of 
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these lipids. This was primarily due to a difference in POPC solubility in the 
ordered domains in PSM and DPPC. When cholesterol was replaced by Chol-PC, 
the Lo phase no longer formed, further confirming our previous anisotropy 
results showing that Chol-PC is unable to induce order in PSM or DPPC bilayers. 
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Figure 18. Lifetime analysis of tPa in ternary bilayers. POPC was present at 60 mol% 
and PSM or DPPC at 40 mol%. To this the indicated amounts of either cholesterol or 
Chol-PC was added. tPa was present at 0.5 mol% and total lipid concentration was 0.1 
mM. Each value is the average of three different experiments with ± SEM. The figure is 
adapted from paper III with permission of ACS Publications. 
 
5.4. Cholesteryl phosphocholine as a potent solvent-free ceramide 
deliverer 
Ceramides are important in cell signaling (241-245) and as regulators in cell 
growth, proliferation and differentiation (149;246;247). Because of their 
hydrophobicity ceramides are poorly soluble in aqueous solutions and thus 
direct addition of naturally occurring ceramides to cultured cells is difficult. 
Short-chain ceramides dissolved in small amounts of organic solvent have been 
successfully incorporated in cell in culture but another possibility would be to 
use liposomal complexes. Short-chain ceramides are more potent in affecting cell 
viability compared to their longer counterparts, possibly due to higher cellular 
uptake (248;249). In our previous work we investigated the formation of stable 
bilayer vesicles composed of Chol-PC and a saturated ceramide, PCer (paper III). 
These complexes could serve as a new and potent solvent free way to deliver 
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ceramides to cultured cells. PCer is difficult to deliver to cells because of its 
relative hydrophobicity and it easily crystallizes in DMSO, commonly used to 
deliver lipids to cultured cells. We therefore chose to study delivery of short-
chained ceramides in order to be able to compare the two methods. To 
investigate if the Chol-PC/ceramide lipid complexes can be used to deliver 
ceramide to cultured cells we have compared the bioactivity of N-hexanoyl 
ceramide (C6-Cer) when presented to HeLa or FRTL-5 cells, either in DMSO or as 
a complex with Chol-PC.  
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Figure 19. Incorporation of [3H]C6-Cer or [3H]Chol-PC into FRTL-5 cells. The cells were 
exposed for the indicated times to 0.05 mM of [3H]C6-Cer/Chol-PC, [3H]C6-Cer/DMSO 
or C6-Cer/[3H]Chol-PC. The uptake was normalized to cell protein amounts and zero 
time labeling was subtracted. Each value is an average from 6 dishes ± SEM. The figure 
is adapted from paper IV with the permission of the authors. 
 
5.4.1. Cellular uptake of [3H]C6-ceramide from different formulations 
To determine if cells are able to take up C6-Cer from the Chol-PC/C6-Cer 
complexes we measured the uptake of [3H]C6-Cer either in a complex with Chol-
PC (at equimolar ratio) or dissolved in DMSO. FRTL-5 cells were exposed to 0.05 
mM of [3H]C6-Cer and the cell associated labeling was measured over a 4 hour 
time period (Fig. 19). We also studied [3H]Chol-PC/C6-Cer complex to monitor 
the uptake of Chol-PC. The cell associated C6-Cer increased curvi-linearly with 
time and a more efficient cell association was achieved when C6-Cer was 
dissolved in DMSO then when complexed with Chol-PC (Fig. 19). Chol-PC 
association was also found to be time dependent and larger than that seen for 
C6-Cer. The fate of C6-Cer taken up by cells has already been studied in cultured 
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cancer cells (250) whereas the fate of Chol-PC was still unknown. It was therefore 
of value to study the fate of Chol-PC once inside the cells. We measured the 
extent of hydrolysis of [3H]Chol-PC (to [3H]Chol) and followed incorporation of 
the label into [3H]cholesteryl esters. An increase in cholesteryl ester concentration 
in cells is an indicator of cholesterol influx into the cells (251). After 4h only 
8.9±1.9% of [3H]Chol-PC was hydrolyzed to [3H]Chol and only 0.5±0.1% was 
further converted into cholesteryl esters. We therefore concluded that even 
though Chol-PC enters the cell it has no significant effect on the cellular mass of 
free cholesterol. 
5.4.2. Ceramide inhibits the proliferation of FRTL-5 and HeLa cells 
Since previous studies have shown that proliferation of FRTL-5 cells is inhibited 
by ceramide (252;253) we decided to compare how C6-Cer complexed with Chol-
PC or C6-Cer dissolved in DMSO affect FRTL-5 cell proliferation by measuring 
incorporation of [3H]thymidine into cellular DNA (Fig. 20A). Thymidine 
incorporation can be used as a proliferation marker since dividing cells will have 
thymidine bound to their DNA. After 48 h incubation the cells exposed to C6-Cer 
had incorporated significantly less thymidine than the control cells. There was a 
difference between C6-Cer dissolved in DMSO or in complex with Chol-PC, the 
latter displaying a lower incorporation of thymidine (Fig. 20). Further support 
for the results was obtained by counting the cell number (Fig. 20B). The 
experiment was also repeated with HeLa cells with similar results (Fig. 3C in 
paper IV). Effects ceramide were also seen when C6-Cer prepared from L-erythro-
sphingosine or D-erythro-sphinganine were used (Fig. 3D in paper IV) indicating 
that the stereochemistry was not of importance to obtain the observed effects. To 
determine that it was in fact C6-Cer and not Chol-PC that caused the observed 
effects we performed the same experiments using chol/Chol-PC complexes, 
cholesterol dissolved in DMSO or Chol/mβCD complexes (Fig. 20C). All of these 
constructs failed to inhibit thymidine incorporation nor did they stimulate it, 
indicating that the effects observed were indeed due to C6-Cer.  
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Figure 20. The effect of C6-Cer on FRTL-5 
cell proliferation measured by thymidine 
incorporation (panels A and C) or cell count 
(panel B). FRTL-5 cells were pre-incubated 
with the indicated lipid mixtures for 48 h. 
Thymidine incubation time was 4 h (panels A 
and C). Lipid concentration was 50 µM and 
each value is a mean of at least three different 
experiments ± SEM. The figure is adapted 
from paper IV with the permission of the 
authors. 
 
5.4.3. Ceramide Induces Apoptosis in the FRTL-5 Cells 
Short-chain ceramides are known to induce apoptosis in FRTL-5 cells (253). We 
therefore tested how C6-Cer in complex with Chol-PC compared to C6-Cer 
dissolved in DMSO in inducing apoptosis (Fig. 21). FRTL-5 cells were exposed to 
the formula for 48 hours and then analyzed with fluorescence-activated cell 
sorting (FACS). Dishes not exposed to C6-Cer had less than 5% apoptotic cells 
after 48h whereas the cells treated with C6-Cer displayed a dramatic increase of 
apoptotic cells, the C6-Cer/Chol-PC complex treatment being the most effective 
(Fig. 21). Chol/Chol-PC complexes were used to control that the uptake of Chol-
PC did not affect the apoptosis (Fig. 21). The results showed no change as 
compared to the untreated cells indicating that the apoptotic effect was indeed 
due to C6-Cer. 
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Figure 21. Induction of apoptosis in FRTL-5 cells by C6-Cer measured by cell counting. 
Cells were exposed to the indicated mixtures for 48 h and the proportion of apoptotic cells 
was counted. Each bar value is a mean of three different experiments ±SEM. *p<0.05, 
***p<0.0001, NS = no significance. The figure is adapted from paper IV with the 
permission of the authors. 
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6. DISCUSSION 
6.1. Effect of acyl chain order on cholesterol partitioning 
Numerous studies have shown that several structural properties affect a sterols 
affinity for phospholipid bilayers (75;200;230;254;255). Cholesterol might either 
have a preference for certain phospholipids, e.g. those with larger head groups 
(75;200;230), saturated chains, or an aversion for others, e.g. with polyunsaturated 
acyl chains (254;255) forcing it to interact with other phospholipids. In paper I we 
used CTL as an analog for cholesterol. These two sterols are not identical; the 
double bond in the B and C ring of CTL yields it more polar and changes its 
planarity compared to cholesterol (192;256;257). Despite these differences, CTL 
partitions into the Lo phase and condenses bilayer packing as well as increases 
the acyl chain order (115;258-260). Although the absolute partitioning values are 
not the same for CTL and cholesterol, the relative partitioning of CTL between 
cyclodextrin and bilayer membranes is similar to that of cholesterol (258;259), 
thus making CTL a useful probe for measuring sterol partitioning between 
cyclodextrin and different lipid bilayers. The lipids used in the study are 
common in the cellular membranes of most cells (206;261;262) and were chosen 
because they are fluid at the temperature range where reliable CTL 
measurements are feasible. The PC and SM lipids studied were also fairly 
symmetric regarding the length of the  acyl chains, eliminating the possible effect 
of interdigitation (263).  
Our results revealed that at equal DPH anisotropy the affinity of CTL was 
highest for SM bilayers and lowest for 14:0/14:0-PC bilayers. This was true also 
for equal CTL anisotropy and deuterium order parameter indicating that CTL 
interacts more favorably with SM compared to PC when the acyl chain order 
parameter is equal. The difference between SM and PC also increased with 
increasing acyl chain order (decreasing temperature). This could be explained by 
the effects of temperature on the hydrogen bonding network, i.e. the lower the 
temperature the stronger the hydrogen bonds due to decreased thermal motions. 
Since SM can form more hydrogen bonds than PC, the net increase in hydrogen 
bond strength will be larger for SM than PC when the temperature is lowered. 
MD simulations have shown that SM can form both inter and intralipid 
hydrogen bonds (17) which decrease the lateral diffusion and rotational motion 
of SM and thereby indirectly strengthen the interactions with cholesterol. 
Hydrogen bonding between SM and cholesterol are still debated (203) (see 
above). The importance of SM hydrogen bonds is indicated in studies where the 
46 
 
hydrogen bonds was abolished upon methylation of the OH or NH groups of SM 
which led to the abolishment of SM-cholesterol interactions (262). Studies that 
have shown that the higher acyl chain order in SM compared to PC plays a role 
have all been done in mixed bilayers (111;200;258). In such mixtures SM might 
prefer to hydrogen bond with cholesterol instead of PC, whereas our data is 
focused on pure systems where the sterol can only choose to act with either PC 
or SM. Although SM and PC share the same head group its dynamics and 
orientation might differ. Several studies have shown that head group properties 
are of importance for Chol/PC interactions (75;113;264). MD simulations on PSM 
and DPPC point to minor differences in the head group orientation (17). These 
findings are further supported by NMR studies indicating differences in SM and 
PC head group orientation (265-267).  
6.2. Effect of an amino group on the 3β carbon of cholesterol 
In paper II we have explored the role of the polar moiety of cholesterol by 
changing it from a hydroxyl group to a (partially) positively-charged amino 
group. These subtle changes in the sterol structure could to discover which 
structures are important for maintaining the intramolecular interactions required 
for sterol membrane function. The hydroxyl head group of cholesterol helps to 
orient cholesterol in the bilayer (268). Replacing it with a partially charged amino 
group is unlikely to affect the orientation since both the hydroxyl and the amino 
group are of roughly the same size and both have the capability to form 
hydrogen bonds with adjacent lipids. However, a change in the molecule tilt 
angle in relation to the bilayer normal is possible. One indication that this indeed 
takes place is that aminocholesterol was slightly less effective in ordering DPPC 
bilayers compared to cholesterol. This effect is not seen for PSM/sterol bilayers, 
probably due to different electrostatic interactions between PSM and the sterol. 
The positive charge could also affect solvation and thus the depth of penetration 
of the sterol. This option is supported by the previously reported increase of the 
inter-bilayer translocation of aminocholesterol when compared to cholesterol 
(269). Our DSC measurements showed that at lower sterol concentrations (5-15 
mol%) aminocholesterol and cholesterol displays very similar effect on the 
thermotropic behavior of PSM and DPPC. However, at higher concentrations (20 
mol%) aminocholesterol almost abolished the transition enthalpy whereas with 
cholesterol a residual transition enthalpy. The melting profile of 
PSM/aminocholesterol bilayers was also more complex compared to PSM/Chol, 
probably because of the positive charge and how it affects the interactions with 
PSM. The hydrogen bonding between PSM and aminocholesterol is also likely to 
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be different from that of DPPC and aminocholesterol. DPH anisotropy data 
together with DSC and c-Laurdan measurements indicate that aminocholesterol 
is able to participate in a liquid ordered phase similar to cholesterol or saturated 
phospholipids. Previous studies have shown that in a ternary system of 
POPC/PSM or POPC/DPPC and cholesterol the sterol will partition into the 
ordered domains formed by PSM or DPPC and increases the stability of these 
domains probably by increasing van der Waals interactions or by excluding 
POPC molecules from these domains (270). When the sterol was replaced by 
aminocholesterol, the stabilization effect disappeared, apparently because of 
more unfavorable interactions with the ordered lipids or because a larger portion 
of aminocholesterol partitioned into the POPC rich phase. Experiments with tPa 
measurements indicated that aminocholesterol was indeed able to form liquid 
ordered domains together with PSM and DPPC, although those domains were 
less ordered compared to cholesterol containing domains.  
6.3. Effect of a large head group on sterol behavior 
6.3.1. Interactions with other membrane lipids 
Studies by Gotoh et al. showed that a sterol phosphate can form stable bilayers 
together with cholesterol or saturated diacylglycerol (240). In paper III we 
explored this issue in more detail to understand how the shape of interacting 
molecules would affect these interactions, mainly by manipulating head group to 
acyl chain volume ratio. Both cholesterol and ceramide induce negative 
membrane curvature and the inverted cone shape of the molecules prevents 
them from forming stable lamellar bilayers on their own. When ceramide 
acquires a large head group in the form of a phosphatidylcholine, becoming a 
SM the acyl chain to head group volume will change. The change in lipid shape 
will allow the SM to form a stable lamellar bilayer on its own and also together 
with cholesterol and/or ceramide.  We set out to investigate how cholesterol with 
a large head group (phosphocholine) would interact with cholesterol and 
ceramide or with saturated or unsaturated phospholipids in model bilayers. 
First, we confirmed the results by Gotho et al. showing that Chol-PC forms 
bilayers together with cholesterol. We also extended the experiments to 
ceramides which have a structure similar to diacylglycerol but with the ability to 
form more extensive hydrogen bonding networks (152). Both GUVs and 
unilamellar LUVs could be formed. The c-Laurdan probe is sensitive to 
interfacial hydration (271) which makes it suitable to study the interfacial 
packing density of lipid bilayers. All systems tested showed low interfacial 
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hydration at 20 °C. At this temperature PSM bilayers are in the gel state and have 
a GP value of 0.42 (71). Based on the GP value one could conclude that Chol-
PC/PCer bilayers, with a GP of about 0.35, are similarly hydrated as PSM and be 
gel-like. However, tPa lifetime measurements displayed much lower values for 
Chol-PC/PCer (9-18 ns) than for pure PSM bilayers (~32 ns (229)). In fact, the 
lifetime obtained for Chol-PC/PCer is much closer to those reported for 
PSM/Chol bilayers in a liquid-ordered state (229). The reason for the fluid state of 
the Chol-PC/Cer bilayers is probably due to the rough surface of Chol-PC with 
protruding methyl groups in the sterol body which prevents efficient van der 
Waals interactions between the lipids, thus weakening the packing. The 
formation of Chol-PC/Chol bilayers can largely be explained by the umbrella 
model; a lipid with a large head group can solubilize a co-lipid with a small head 
group (113;230). The phosphocholine head group of Chol-PC can shield 
cholesterol from unfavorable water exposure, thus favoring a bilayer formation.  
It is known that SM and a saturated PC do mix and that the ideality of the 
mixture depends on the hydrophobic interactions between the acyl chains (272). 
When Chol-PC was added to either PSM or DPPC bilayers a dramatic 
destabilization of the lipid gel phase took place. This destabilization is most 
likely due to mismatch between the head group and the hydrocarbon volume. It 
has been estimated that PSM has a volume per lipid of 1175 Å3 (273), whereas the 
volume for cholesterol is only 630 Å3 (274). If PSM is stripped of its head group 
(creating PCer) the volume drops to 990 Å3 (273). Based on these numbers it 
becomes clear that the hydrophobic part of Chol-PC will not be able to fill the 
intermolecular void when it is mixed with PSM, resulting in the observed 
destabilization. 
6.3.2. Cholesteryl phosphocholine/ceramide vesicles as potent ceramide vehicles 
Ceramides are bioactive molecules that affect many cellular processes e.g. via 
ceramide rich domains, enzyme modulating or formation of membrane pores. 
Ceramides are able to induced cytochrome leakage from the mitochondria (275). 
To study the effects ceramide in cells one can generate ceramides either through 
the action of sphingomyelinases degrading SMs to ceramides or by transferring 
ceramides from an extracellular carrier in the medium. The hydrophobicity of 
ceramides makes it difficult to transport them via the aqueous culture media and 
thus organic solvents such as DMSO are often used. In paper III we showed that 
Chol-PC is able to form stable fluid bilayers together with C16-Cer. In paper IV 
we explored the possibility to use such complexes to deliver short-chain 
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ceramides to cells. The antiproliferation effects of short-chain ceramides are well 
documented (147;276) and in this study we chose to focus on C6-Cer, known to 
affect cell growth and apoptosis. Chol-PC/C6-Cer complex was indeed much 
more effective in prohibiting cell growth and induce apoptosis than C6-Cer 
dissolved in DMSO although radiolabeled C6-Cer was taken up more efficiently 
when in DMSO. The higher uptake is likely caused by the crystallization of the 
ceramide when mixed with the medium and crystals sticking to the cell surface 
rather than being taken up into the cell. C6-Cer was effective in inhibiting cell 
growth in both FRTL-5 and HeLa cells and unexpectedly the same effect was 
seen for dihydroceramide or the unnatural L-erythro form of C6-Cer. It is 
therefore evident that even though several studies have noted the importance of 
right stereochemistry (277-279), for cell growth both the L and the D-isomers are 
equally effective. Observing the apoptotic levels of treated dishes revealed that 
the complex-treated cells displayed the highest levels of apoptotic cells, 
indicating good ceramide entry into the cells. To verify that the effect was indeed 
due to the effect of C6-Cer, we studied Chol-PC/Chol vesicles and observed no 
effect on the cells, thus showing that the observed effect was indeed due to 
ceramide.  
The cellular entry mechanism and the fate of C6-Cer inside the cell was not 
explored in this work. Ceramides dissolved in DMSO are likely to precipitate 
when added to the aqueous culture media and thus the bioavailability of 
crystalline ceramide is low. By mixing the ceramide with Chol-PC the 
crystallization can be avoided. The fluid nature of the bilayer and the fact that 
ceramide probably prefers to interact with phospholipids over Chol-PC would 
allow for transfer of monomeric ceramide from the complex to the plasma 
membrane. It is know that the hydrophobicity of lipids correlate negatively with 
the efficiency of transfer between membranes (280;281). The longer the acyl 
chains the slower the transfer rate. This was the main reason for choosing short-
chain C6-Cer in this study. It is possible that some of the Chol-PC/Cer complex 
could fuse with the plasma membrane. Once the ceramide has entered the cell it 
could be re-acylated to form long-chained ceramides. The ceramide would also 
need to be transferred to the ER and mitochondrial membranes and the nucleus 
in order to induce the observed effects.  
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7. CONCLUSIONS 
The results in paper I clearly demonstrate that acyl chain order markedly 
influence the sterol/phospholipid interactions; however when the acyl chain 
order is equal the sterol will prefer to interact with SM over PC. It seems that 
sterols have a larger ordering effect on the acyl chains of SM, possibly due to the 
stronger interactions between SM and sterol compared to PC. Both differences in 
head group area and hydrogen bonding properties could be the reason for this 
difference. SM cholesterol interactions are important for the formation of ordered 
domains in cell membranes. These domains may function as cell signaling 
platforms, aiding in receptor clustering and thereby be a vital part of proper 
signaling transduction and support important cellular functions. 
In paper II the hydroxyl group of cholesterol was changed to an amine group, 
making it more polar. The results indicated that this modification did not largely 
affect the membrane behavior of aminocholesterol compared to cholesterol. This 
is promising in the aspect of using aminocholesterol as a cationic lipid in 
biotechnical applications where a positive charge and a competent sterol are 
needed for optimal function. 
In paper III we investigated how a large phosphocholine head group on 
cholesterol (Chol-PC) affects its membrane properties. It was clear that Chol-PC 
preferred to interact with lipids having small head groups, i.e. cholesterol or 
ceramides and that it disrupted the packing of lipids with larger head groups, i.e. 
PSM and DPPC. The results indicated the importance of lipid shape in forming 
stable bilayers and the prospect of stable and fluid vesicles with a high ceramide 
content may open up new possibilities in drug delivery and other medical 
applications.  
In paper IV we explored the use of Chol-PC/C6-Cer lipo-complexes as a solvent 
free ceramide delivery system for cultured cells. The results showed that the 
complex was much more efficient in causing inhibition of proliferation, apoptosis 
compared to C6-Cer delivered dissolved in DMSO. We have proposed that C6-
Cer in complex with Chol-PC provides a better bioavailability compared to the 
use of solvents and can be successfully used to deliver ceramides to cultured 
cells.  
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